- Home
- ASTL vs RLAY Comparison
ASTL vs RLAY Comparison
Compare ASTL & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTL
- RLAY
- Stock Information
- Founded
- ASTL 1902
- RLAY 2015
- Country
- ASTL Canada
- RLAY United States
- Employees
- ASTL N/A
- RLAY N/A
- Industry
- ASTL Steel/Iron Ore
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASTL Industrials
- RLAY Health Care
- Exchange
- ASTL Nasdaq
- RLAY Nasdaq
- Market Cap
- ASTL 682.6M
- RLAY 620.4M
- IPO Year
- ASTL N/A
- RLAY 2020
- Fundamental
- Price
- ASTL $4.67
- RLAY $2.08
- Analyst Decision
- ASTL
- RLAY Strong Buy
- Analyst Count
- ASTL 0
- RLAY 10
- Target Price
- ASTL N/A
- RLAY $19.33
- AVG Volume (30 Days)
- ASTL 1.4M
- RLAY 2.6M
- Earning Date
- ASTL 03-12-2025
- RLAY 05-01-2025
- Dividend Yield
- ASTL 3.91%
- RLAY N/A
- EPS Growth
- ASTL N/A
- RLAY N/A
- EPS
- ASTL N/A
- RLAY N/A
- Revenue
- ASTL $1,706,096,151.00
- RLAY $10,007,000.00
- Revenue This Year
- ASTL $17.08
- RLAY N/A
- Revenue Next Year
- ASTL $8.25
- RLAY $420.18
- P/E Ratio
- ASTL N/A
- RLAY N/A
- Revenue Growth
- ASTL N/A
- RLAY N/A
- 52 Week Low
- ASTL $5.06
- RLAY $2.26
- 52 Week High
- ASTL $12.14
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- ASTL 24.86
- RLAY 26.29
- Support Level
- ASTL $5.25
- RLAY $3.05
- Resistance Level
- ASTL $5.66
- RLAY $3.08
- Average True Range (ATR)
- ASTL 0.26
- RLAY 0.18
- MACD
- ASTL -0.06
- RLAY -0.07
- Stochastic Oscillator
- ASTL 2.49
- RLAY 2.29
About ASTL Algoma Steel Group Inc.
Algoma Steel Group Inc is a Canadian company engaged in the production of clean and consistent light gauge steel. The company offers a range of hot and cold rolled steel sheet and plate products. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).